Factors influencing the effectiveness of trabeculectomy: following materials of the City Multidisciplinary Hospital No. 2
- 作者: Аntonova А.1,2, Nikolaenko V.1,2, Brzheskiy V.3, Vuks A.4
-
隶属关系:
- City Multidisciplinary Hospital No. 2
- Saint Petersburg State University
- St. Petersburg State Pediatric Medical University
- V.M. Bekhterev St. Petersburg Psychoneurological Research Institute
- 期: 卷 15, 编号 4 (2022)
- 页面: 35-44
- 栏目: Original researches
- URL: https://journals.rcsi.science/ov/article/view/144091
- DOI: https://doi.org/10.17816/OV159363
- ID: 144091
如何引用文章
详细
BACKGROUND: Despite the ever-expanding arsenal of IOP-lowering surgeries, trabeculectomy remains the most common procedure amongst them. Therefore, the identification of factors reducing its effectiveness and potentially being able to change the surgical treatment plan is of particular importance.
AIM: To identify factors reducing trabeculectomy effectiveness.
MATERIALS AND METHODS: The study group consisted of 443 consecutively enrolled patients who were operated in 2016–2020 in Saint Petersburg City Multidisciplinary Hospital No. 2 for primary open-angle decompensated glaucoma and then observed for 6 to 24 months. Using statistical research methods, factors that significantly affected the impact of the procedure were identified.
RESULTS: The main predictors of trabeculectomy failure following the order of decreasing importance of established relations (p) were: loss of effectiveness of the preceding IOP-lowering procedure (р = 0.0001), dry eye syndrome (р = 0.013), number of drop instillations per day (р = 0.041), and excessive preservative load due to unnecessarily aggressive topical glaucoma treatment (р = 0.039). An obvious demonstration of excessive therapy is a simultaneous administration of four IOP-lowering medications. It also causes scarring of the procedure area, especially in patients previously operated for glaucoma. Null preservative load and prostaglandin monotherapy are associated with guaranteed “complete success” of trabeculectomy. Unlike the intensity of medical glaucoma treatment, its duration does not have such a significant impact on trabeculectomy outcomes (р = 0.270). Close to a significant one is the relationship between poor surgical outcomes and advanced stages of the disease (р = 0.052).
CONCLUSIONS: The main factors affecting the effectiveness of trabeculectomy were failure of the previous IOP-lowering surgeries; concomitant dry eye syndrome, arising or being aggravated by unduly intense and prolonged pharmacological effects on the eye surface; as well as delayed appliance for surgical IOP normalization at advanced disease stages.
作者简介
Аnastasiia Аntonova
City Multidisciplinary Hospital No. 2; Saint Petersburg State University
编辑信件的主要联系方式.
Email: dr.antonova.av@gmail.com
ORCID iD: 0000-0002-2639-2765
SPIN 代码: 2166-3936
Ophthalmologist, Assistant of the Department of ENT Diseases and Ophthalmology
俄罗斯联邦, 5, Uchebnyi lane, Saint Petersburg, 194354; Saint PetersburgVadim Nikolaenko
City Multidisciplinary Hospital No. 2; Saint Petersburg State University
Email: dr.Nikolaenko@mail.ru
ORCID iD: 0000-0002-6393-1289
SPIN 代码: 4906-2542
Dr. Sci. (Med.), Deputy Head Doctor for Ophthalmology, Professor of the Department of ENT Diseases and Ophthalmology
俄罗斯联邦, 5, Uchebnyi lane, Saint Petersburg, 194354; Saint PetersburgVladimir Brzheskiy
St. Petersburg State Pediatric Medical University
Email: vvbrzh@yandex.ru
ORCID iD: 0000-0001-7361-0270
Dr. Sci. (Med.), Professor, Head of the Department of Ophthalmology
俄罗斯联邦, Saint PetersburgAleksandr Vuks
V.M. Bekhterev St. Petersburg Psychoneurological Research Institute
Email: ayavuks@bekhterev.ru
ORCID iD: 0000-0002-6700-0609
Head Specialist
俄罗斯联邦, Saint Petersburg参考
- Egorova EA, Ericheva VP, editors. Natsionalnoe rukovodstvo po glaukome dlya prak-tikuyushchikh vrachei. Moscow: GEHOTAR-Media, 2019. 384 p. (In Russ.) doi: 10.33029/9704-5442-8-GLA-2020-1-384
- European Glaucoma Society Terminology and Guidelines for Glaucoma, 5. Savona: PubliComm, 2020. 169 p.
- Avo-portal.ru [Internet]. Klinicheskie rekomendatsii. Glaukoma pervichnaya otkrytougol’naya. 2020 [cited: 2022 Nov 25]. Available at: http://avo-portal.ru/doc/fkr/item/246-glaukomaotkrytougolnaya (In Russ.)
- Tanna AP. Basic and Clinical Science Course. Section 10. Glaucoma. American Academy of Ophthalmology. San Francisco: AAO, 2022–2023. 319 p.
- Weinreb RN, Ramulu P, Topouzis F, et al. editors. 11th Consensus Meeting: Glaucoma Surgery. World Glaucoma Association; 2019 Mar 26; Melbourne, Australia. Available at: https://wga.one/wga/consensus-11/
- Brzheskii VV. Glaukoma i sindrom “sukhogo glaza”. Moscow: BORGES, 2018. 228 p. (In Russ.)
- Gupta PK, Drinkwater OJ, Van Dusen KW, et al. Prevalence of ocular surface dysfunction in patients presenting for cataract surgery evaluation. J Cataract Refract Surg. 2018;44(9):1090–1096. doi: 10.1016/j.jcrs.2018.06.026
- Pérez-Bartolomé F, Martínez-de-la-Casa JM, Arriola-Villalobos P, et al. Ocular surface disease in patients under topical treatment for glaucoma. Eur J Ophthalmol. 2017;27(6):694–704. doi: 10.5301/ejo.5000977
- Antonova AV, Nikolaenko VP, Brzheskiy VV. Realization of a cascade treatment algorithm for glaucoma in St. Petersburg. Russian Journal of Clinical Ophthalmology. 2021;21(3):123–128. (In Russ.) doi: 10.32364/2311-7729-2021-21-3-123-128
- Erichev VP, Petrov SYu, Antonov AA, Volzhanin AV. International standards of clinical trials in glaucoma surgery. National Journal glaucoma. 2016;15(2):102–112. (In Russ.)
- Shaarawy T, Grehn F, Sherwood M, editors. Guidelines on design and reporting of glaucoma surgical trials. World Glaucoma Association. Amsterdam: Kugler Publications, 2009. 83 p.
- Oblovatskaya ES, Nikolaenko VP. Ahmed valve implant and its place in the surgical treatment of glaucoma. National Journal Glaucoma. 2022;21(2):35–41. (In Russ.) doi: 10.53432/2078-4104-2022-21-2-35-41
- Fogagnolo P, Torregrossa G, Tranchina L, et al. Tear film osmolarity, ocular surface disease and glaucoma: a review. Curr Med Chem. 2019;26(22):4241–4252. doi: 10.2174/0929867326666190725160621
- Nijm LM, De Benito-Llopis L, Rossi GC, et al. Understanding the dual dilemma of dry eye and glaucoma: an international review. Asia Pac J Ophthalmol (Phila). 2020;9(6):481–490. doi: 10.1097/APO.0000000000000327
- Voicu L, Salim S. New strategies for the management of ocular surface disease in glaucoma patients. Curr Opin Ophthalmol. 2021;32(2):134–140. doi: 10.1097/ICU.0000000000000739
- Safonova TN, Fedorov AA, Zabegaylo AO, et al. Treatment of dry eye syndrome by primary glaucoma. National Journal Glaucoma. 2015;14(4):36–43. (In Russ.)
- Egorova GB, Averich VV. Reducing cytotoxic action of the preservative employed in ophthalmic hypotensive medications with tear replacement therapy. The Russian Annals of Ophthalmology. 2018;134(3):48–56. (In Russ.) doi: 10.17116/oftalma2018134348
- Makashova NV, Vasilieva AE, Kolosova OYu. Effects of artificial tears on ocular surface in glaucomatous patients with long-term instillation of preserved antiglaucoma eye drops. The Russian Annals of Ophthalmology. 2018;134(2):59–65. (In Russ.) doi: 10.17116/oftalma2018134259-65
- Tailor R, Batra R, Mohamed S. A national survey of glaucoma specialists on the preoperative (trabeculectomy) management of the ocular surface. Semin Ophthalmol. 2016;31(6):519–525. doi: 10.3109/08820538.2014.986585
- Erichev VP, Volzhanin AV. Non-preservative glaucoma treatment. National Journal glaucoma. 2020;19(1):69–78. (In Russ.) DOI: 10.25700/ NJG.2020.01.10
- Baudouin C. Ocular Surface and External Filtration Surgery: Mutual Relationships. Dev Ophthalmol. 2017;59:67–79. doi: 10.1159/000458487
- Baudouin C, Kolko M, Melik-Parsadaniantz S, Messmer EM. Inflammation in glaucoma: From the back to the front of the eye, and beyond. Prog Retin Eye Res. 2021;83:100916. doi: 10.1016/j.preteyeres.2020.100916
- Astakhov YuS, Nikolaenko VP, editors. Oftalmologiya. Farmakoterapiya bez oshibok II. Moscow: E-noto, 2021. 800 p. (In Russ.)
- Boimer C, Birt CM. Preservative exposure and surgical outcomes in glaucoma patients: The PESO study. J Glaucoma. 2013;22(9): 730–735. doi: 10.1097/IJG.0b013e31825af67d
- Broadway DC, Grierson I, O’Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol. 1994;112(11):1446–1154. doi: 10.1001/archopht.1994.01090230060021
- Broadway DC, Grierson I, O’Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol. 1994;112(11):1437–1145. doi: 10.1001/archopht.1994.01090230051020
- Richter CU, Shingleton BJ, Bellows AR, et al. The development of encapsulated filtering blebs. Ophthalmology. 1988;95(9):1163–1168. doi: 10.1016/s016-6420(88)33041-1
- Lavin MJ, Wormald RP, Migdal CS, Hitchings RA. The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol. 1990;108(11):1543–1548. doi: 10.1001/archopht.1990.01070130045027